Evidence map›Paper›PMID 40498665›Full record

ArticleDrug and alcohol review2025

Vaping cessation strategies and triggers for relapse amongst people from New Zealand who have vaped.

Mehdi Rahimi, Bodo Lang, Lion Shahab, Jamie Brown, Amanda Palmer, Joya Kemper, Chris Bullen, George Laking, Vili Nosa, Varsha Parag and 1 more

Abstract read
In one paragraph

Article in Drug and alcohol review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mehdi RahimiSchool of Counselling, Human Services and Social Work, University of Auckland, Auckland, New Zealand.
Bodo LangSchool of Communication, Journalism and Marketing, Massey University, Auckland, New Zealand.
Lion ShahabInstitute of Epidemiology & Health, University College London, London, UK.
Jamie BrownInstitute of Epidemiology & Health, University College London, London, UK.
Amanda PalmerDepartment of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Joya KemperUniversity of Canterbury Business School, University of Canterbury, Christchurch, New Zealand.ORCID 0000-0002-1778-8346
Chris BullenGeneral Practice and Primary Healthcare, School of Population Health, The University of Auckland, Auckland, New Zealand.ORCID 0000-0001-6807-2930
George LakingTe Aka Māturanga Matepukupuku, Centre for Cancer Research, The University of Auckland, Auckland, New Zealand.
Vili NosaPacific Health, School of Population Health, The University of Auckland, Auckland, New Zealand.
Varsha ParagNational Institute for Health Innovation, School of Population Health, The University of Auckland, Auckland, New Zealand.
Natalie WalkerSocial and Community Health, School of Population Health, The University of Auckland, Auckland, New Zealand.ORCID 0000-0001-5939-5009

Funding

University of Auckland, Faculty of Medical and Health Sciences Research and Development Fund (Seed Funding Round 2022) 3727243
6 · The paper itself

Abstract

introductionIn New Zealand (NZ) vapes (e-cigarettes) are a government-endorsed strategy to help people stop smoking, as well as being used recreationally by people who have never smoked. Nicotine vapes are addictive and many users want to quit. We surveyed current and past users of nicotine vapes to gather insights about their vaping cessation reasons and strategies.

methodsIn December 2022, we undertook a web-based survey in NZ using market research survey panels. Eligible panellists were aged ≥16 years, did not currently smoke and had vaped nicotine. Questions focused on demographics, smoking and vaping status, vaping dependence, strategies used to quit vaping, and triggers for vaping relapse.

resultsOne thousand one hundred nineteen participants completed the survey: 144 had never smoked; 975 used to smoke, 401 currently vaped nicotine, and 718 used to vape nicotine. Participants were predominantly aged ≥25 years (89%); 63% were female, and 21% were Indigenous Māori and/or Pacific. Predictors of vaping dependence were having smoked or vaped for ≥2 years and vaping >3% nicotine. Reasons for trying to quit vaping included health concerns, disliking feeling dependent, and cost. Quitting strategies included stopping abruptly, nicotine tapering and family/friend support. Triggers for relapse were stress, being around others who vaped and nicotine withdrawal. DISCUSSION AND

conclusionIn NZ reasons to quit and triggers to return to vaping are similar to quitting smoking. Until more research is available, it seems appropriate to support people who wish to stop vaping with similar strategies used to support people to quit smoking.

Indexed as

Smoking CessationVapingAdolescentAdultAgedElectronic Nicotine Delivery SystemsFemaleHumansMaleMiddle AgedNew ZealandRecurrenceSurveys and QuestionnairesYoung Adultcessationdependencerelapsevaping

Identifiers

PMID40498665
PMCPMC12228022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.